Advancing Pulmonary Arterial Hypertension Therapy through Encapsulated Mini Tablets: A Dual-Release Strategy for Bosentan and Sildenafil Citrate

Pulmonary Arterial Hypertension (PAH) remains a formidable challenge in cardiovascular therapeutics. Despite numerous pharmacological advances, the disease demands innovative strategies that address both patient compliance and long-term efficacy. This article explores a novel formulation concept—encapsulated mini tablets (MTs)—combining immediate-release Sildenafil…

Navigating the Complexities: The Impact of Neo-Adjuvant Androgen Deprivation on Erectile Function Following Radiotherapy in Prostate Cancer

Understanding the Challenge The landscape of prostate cancer treatment has evolved dramatically, yet one aspect consistently overshadows therapeutic success—erectile dysfunction (ED). External Beam Radiotherapy (EBRT), while highly effective for localized prostate cancer, carries the unfortunate baggage of sexual dysfunction. Complicating…

Understanding the Complex Relationship Between Prostate Cancer and Erectile Dysfunction: Current Trends and Future Directions

Prostate cancer remains a leading cause of cancer-related morbidity among men globally, accounting for significant annual diagnoses and deaths. However, surviving prostate cancer often leads to another challenging condition—erectile dysfunction (ED). Despite successful medical advancements improving prostate cancer prognosis, post-treatment…